Table 1.
PD initiation years | PD assistance 2018-2020 | |||||
---|---|---|---|---|---|---|
‘Pre’ 2015-2017 (n = 52) |
‘Post’ 2018-2020 (n = 72) |
P-value | Independent PD (n = 59) | Assisted PD (n = 13) | P-value | |
Age, in year | 60 (54-73) | 61 (52-69) | .45 | 59 (47-67) | 72 (64-84) | .006 |
Female sex | 23 (44) | 24 (33) | .21 | 21 (35) | 3 (23) | .52 |
Race | ||||||
Black | 8 (15) | 12 (17) | .90 | 11 (19) | 1 (8) | .10 |
Caucasian | 35 (67) | 47 (65) | 40 (68) | 7 (54) | ||
Other | 9 (18) | 13 (19) | 8 (14) | 5 (38) | ||
Cause of kidney failure | ||||||
Glomerulonephritis | 26 (50) | 19 (26) | .003 | 15 (25) | 4 (31) | .99 |
Diabetic nephropathy | 7 (13) | 27 (38) | 21 (36) | 6 (46) | ||
Hypertension | 11 (21) | 9 (13) | 8 (14) | 1 (8) | ||
Other | 8 (16) | 16 (22) | 14(24) | 2(15) | ||
Comorbidities | ||||||
Diabetes | 17 (36) | 40 (56) | .02 | 30 (51) | 10 (77) | .12 |
CAD | 19 (37) | 26 (36) | .96 | 20 (34) | 6 (46) | .53 |
PVD | 8 (15) | 14 (19) | .64 | 10 (17) | 4 (31) | .26 |
CVD | 5 (10) | 11 (15) | .42 | 7 (12) | 4 (31) | .10 |
COPD | 9 (17) | 8 (11) | .43 | 4 (7) | 4 (31) | .03 |
Cancer | 20 (38) | 17 (24) | .07 | 15 (25) | 2 (15) | .72 |
PD as first modality | 26 (50) | 38 (53) | .76 | 30 (51) | 8 (62) | .48 |
KRT duration before PD, in year (n = 60) | 0.3 (0.2-0.5) | 0.5 (0.3-1.3) | .17 | 0 (0-0.6) | 0 (0-0.3) | .27 |
Transplant candidate | 24 (46) | 45 (63) | .10 | 39 (66) | 6 (46) | .21 |
Note. PD = peritoneal dialysis; CAD = coronary artery disease; PVD = peripheral vascular disease; CVD = cerebrovascular disease; COPD = chronic obstructive pulmonary disease; KRT = kidney replacement therapy.